Why Viking Therapeutics Tumbled by More Than 10% This Week
Portfolio Pulse from
Viking Therapeutics' stock fell by over 10% this week due to a new licensing deal by a well-capitalized competitor.
December 20, 2024 | 11:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Viking Therapeutics' stock price dropped by over 10% this week due to a competitor's new licensing deal.
The announcement of a new licensing deal by a well-capitalized competitor negatively impacted Viking Therapeutics' stock, causing a significant drop in its share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100